Media ReleasesAuscann Group Holdings

View All Auscann Group Holdings News

AusCann Announce June 2019 Quarterly Activities and Cashflow Reports

AusCann strengthens strategic partnerships during June Quarter


  • Commencement of Mr Ido Kanyon as new CEO of AusCann
  • First commercial shipment of medical cannabis concentrate from MediPharm Labs completed, representing first ever bulk international shipment of active pharmaceutical ingredient medical cannabis concentrate from Canada to Australia
  • New supply agreement with TasAlk, in line with AusCann’s strategy to de-risk supply chain and secure high-quality pharmaceutical suppliers across the product value chain
For further information please download the attached PDF: Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.